Viatris Stock Is Dirt Cheap And Worth Buying [Seeking Alpha]
Viatris Inc. (VTRS)
Company Research
Source: Seeking Alpha
The decline is likely due to the company's debt burden and stagnant revenues. Despite this, now may be a good time to consider buying VTRS as its valuation is low and there are signs of future improvement in financial performance. I think Viatris may reach $14.52 next year, a 55% increase, trading at 5-6x earnings with ongoing debt reduction and potential new drug approvals. Looking for more investing ideas like this one? Get them exclusively at Beyond the Wall Investing. Learn More » Introduction I wrote about Viatris NASDAQ: VTRS ) shares about 2 years ago when they were trading at $13.63. My "Strong Buy" rating at the time didn't age well, as VTRS's total return showed a negative 25%, while the S&P 500 Index ( SPX SP500 ) returned to 'normalcy' after a severe 2022 drawdown. The most likely reason for the decline in VTRS during the period indicated is the company's debt burden and stagnating revenues: Nevertheless, now may be the right time to consider adding to your
Show less
Read more
Impact Snapshot
Event Time:
VTRS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VTRS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VTRS alerts
High impacting Viatris Inc. news events
Weekly update
A roundup of the hottest topics
VTRS
News
- Viatris: Looks Cheap, But Faces Continued Contraction [Seeking Alpha]Seeking Alpha
- Viatris (VTRS): Reassessing Valuation After Recent Share Price Gains and Evolving Investor Sentiment [Yahoo! Finance]Yahoo! Finance
- Is Viatris' Shift Into Complex Therapies Altering The Investment Case For VTRS? [Yahoo! Finance]Yahoo! Finance
- Viatris Gets FDA Nod for Generic Sandostatin, Shares Regulatory Updates [Yahoo! Finance]Yahoo! Finance
- 1 S&P 500 Stock with Impressive Fundamentals and 2 That Underwhelm [Yahoo! Finance]Yahoo! Finance
VTRS
Earnings
- 11/6/25 - Beat
VTRS
Sec Filings
- 12/8/25 - Form 8-K
- 12/5/25 - Form 8-K
- 12/5/25 - Form 8-K/A
- VTRS's page on the SEC website